Name | N-(4-Chlorophenyl)-N-[2-(3,4-dihydro-2(1H)-isoquinolinyl)-2-oxoethyl]methanesulfonamide |
---|---|
Synonyms |
Methanesulfonamide, N-(4-chlorophenyl)-N-[2-(3,4-dihydro-2(1H)-isoquinolinyl)-2-oxoethyl]-
N-(4-chlorophenyl)-N-[2-(3,4-dihydroisoquinolin-2(1H)-yl)-2-oxoethyl]methanesulfonamide N-(4-Chlorophenyl)-N-[2-(3,4-dihydro-2(1H)-isoquinolinyl)-2-oxoethyl]methanesulfonamide |
Description | TKDC is a small molecule allosteric inhibitor of TREK channels with IC50 of 4.9, 5.2 and 65.9 uM for TREK-1, TREK-2 and TRAAK, respectively; maintains potency for mutant TREK-1 channels with IC50 of 2.4, 2.4 and 2.2 uM for T79A TREK-1, Q83A TREK-1 and Q105A TREK-1, respectively; decreases immobility and induces antidepressant-like effects in mice. |
---|---|
References | References 1. Luo Q, et al. Nat Commun. 2017 Aug 29;8(1):378. View Related Products by Target Potassium Channel |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 588.2±60.0 °C at 760 mmHg |
Molecular Formula | C18H19ClN2O3S |
Molecular Weight | 378.873 |
Flash Point | 309.5±32.9 °C |
Exact Mass | 378.080475 |
LogP | 3.45 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.640 |